• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pneumococcal Vaccination in Immunocompromised Hosts: An Update.免疫功能低下宿主的肺炎球菌疫苗接种：最新进展
Vaccines (Basel). 2021 May 21;9(6):536. doi: 10.3390/vaccines9060536.
2
Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?成人肺炎球菌疫苗接种：我们能从在同一人群中评估13价肺炎球菌结合疫苗（PCV13）和23价肺炎球菌多糖疫苗（PPV23）有效性的观察性研究中学到什么？
Arch Bronconeumol. 2023 Mar;59(3):157-164. doi: 10.1016/j.arbres.2022.12.015. Epub 2023 Jan 7.
3
The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease.肺炎球菌免疫接种对严重慢性肾脏病患者总 B 细胞和抗原特异性 B 细胞的影响。
BMC Immunol. 2019 Nov 12;20(1):41. doi: 10.1186/s12865-019-0325-9.
4
Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis.肺炎球菌多糖疫苗和结合疫苗在老年人及高危人群中预防侵袭性肺炎球菌疾病的疫苗效力：一项系统检索与荟萃分析
Eur Clin Respir J. 2023 Jan 20;10(1):2168354. doi: 10.1080/20018525.2023.2168354. eCollection 2023.
5
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK.英国布里斯托尔对因急性下呼吸道感染住院的成年人肺炎球菌血清型的监测。
Vaccine. 2024 Mar 7;42(7):1599-1607. doi: 10.1016/j.vaccine.2024.02.007. Epub 2024 Feb 8.
6
[Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].[关于预防社区获得性肺炎的建议，以菌血症作为50岁以上人群及19岁以上风险群体侵袭性肺炎球菌感染的主要形式]
Pol Merkur Lekarski. 2014 Feb;36(212):79-87.
7
Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: A retrospective database analysis.美国 65 岁及以上人群的肺炎球菌疫苗接种模式：一项回顾性数据库分析。
Vaccine. 2018 Nov 26;36(49):7574-7579. doi: 10.1016/j.vaccine.2018.10.015. Epub 2018 Oct 31.
8
Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study.在一项为期 5 年的随访队列研究中，比较肺炎球菌疫苗（PPV23）和肺炎球菌结合疫苗（PCV13）在 COPD 患者中的有效性。
Sci Rep. 2021 Aug 5;11(1):15948. doi: 10.1038/s41598-021-95129-w.
9
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.23 价肺炎球菌多糖疫苗预防成人疫苗血清型肺炎球菌肺炎的效果：病例对照试验阴性设计研究。
PLoS Med. 2020 Oct 23;17(10):e1003326. doi: 10.1371/journal.pmed.1003326. eCollection 2020 Oct.
10
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany.德国成人肺炎球菌疫苗接种的潜在成本效益和收益成本比。
Health Econ Rev. 2012 Mar 30;2(1):4. doi: 10.1186/2191-1991-2-4.

引用本文的文献

1
Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review.印度肺炎球菌结合疫苗选择的临床与循证考量：一篇叙述性综述
Hum Vaccin Immunother. 2025 Dec;21(1):2482285. doi: 10.1080/21645515.2025.2482285. Epub 2025 Apr 3.
2
Evaluating immune responses to pneumococcal vaccines.评估对肺炎球菌疫苗的免疫反应。
Asia Pac Allergy. 2023 Sep;13(3):127-131. doi: 10.5415/apallergy.0000000000000114. Epub 2023 Sep 7.
3
Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies.血液系统恶性肿瘤治疗后有症状的继发性免疫缺陷患者的临床和实验室特征
EJHaem. 2023 Apr 1;4(2):339-349. doi: 10.1002/jha2.683. eCollection 2023 May.
4
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.免疫缺陷疾病患儿对肺炎球菌结合疫苗（沛儿13）的IgG抗体反应。
Med Microbiol Immunol. 2023 Feb;212(1):93-102. doi: 10.1007/s00430-022-00759-0. Epub 2023 Jan 3.
5
A comprehensive overview of pneumococcal vaccination recommendations for adults in South Africa, 2022.2022年南非成人肺炎球菌疫苗接种建议综述
J Thorac Dis. 2022 Oct;14(10):4150-4172. doi: 10.21037/jtd-22-287.

本文引用的文献

1
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency.成人继发性免疫缺陷患者疫苗接种综述
Infect Dis Ther. 2021 Jun;10(2):637-661. doi: 10.1007/s40121-021-00404-y. Epub 2021 Mar 9.
2
Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases.生物疗法对自身免疫性炎症疾病患者接种肺炎球菌疫苗后免疫反应的影响。
Vaccines (Basel). 2021 Feb 28;9(3):203. doi: 10.3390/vaccines9030203.
3
Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?HIV感染者的肺炎球菌疫苗接种：肺炎球菌结合疫苗、多糖疫苗还是两者皆用？
EClinicalMedicine. 2020 Nov 29;29-30:100593. doi: 10.1016/j.eclinm.2020.100593. eCollection 2020 Dec.
4
Immunogenicity of pneumococcal vaccination in HIV infected individuals: A systematic review and meta-analysis.HIV感染个体中肺炎球菌疫苗的免疫原性：一项系统评价和荟萃分析。
EClinicalMedicine. 2020 Nov 23;29-30:100576. doi: 10.1016/j.eclinm.2020.100576. eCollection 2020 Dec.
5
The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis.肺炎球菌疫苗接种对成年人心血管疾病的保护作用：系统评价和荟萃分析。
Int J Infect Dis. 2020 Oct;99:204-213. doi: 10.1016/j.ijid.2020.07.038. Epub 2020 Jul 29.
6
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence.免疫原性和安全性的 13 价肺炎球菌结合疫苗在免疫功能低下的患者：现有证据的回顾。
Hum Vaccin Immunother. 2020 Nov 1;16(11):2758-2772. doi: 10.1080/21645515.2020.1735224. Epub 2020 Jun 12.
7
Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study.血液恶性肿瘤患者侵袭性肺炎球菌病风险的差异及时间变化：一项全国性 16 年队列研究结果。
Clin Infect Dis. 2021 Feb 1;72(3):463-471. doi: 10.1093/cid/ciaa090.
8
Development of Next Generation Vaccines Conferring Broad Protection.具有广泛保护作用的下一代疫苗的研发。
Vaccines (Basel). 2020 Mar 17;8(1):132. doi: 10.3390/vaccines8010132.
9
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.人类先天性免疫缺陷：国际免疫学联盟专家委员会 2019 年分类更新。
J Clin Immunol. 2020 Jan;40(1):24-64. doi: 10.1007/s10875-019-00737-x. Epub 2020 Jan 17.
10
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.《免疫实践咨询委员会关于 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗在年龄≥65 岁成人中使用的更新建议》。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075. doi: 10.15585/mmwr.mm6846a5.

免疫功能低下宿主的肺炎球菌疫苗接种：最新进展

Pneumococcal Vaccination in Immunocompromised Hosts: An Update.

作者信息

Froneman Claire, Kelleher Peter, José Ricardo J

机构信息

Department of Respiratory Medicine, Royal Brompton Hospital, London SW3 6NP, UK.

Department of Infectious Disease, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.

出版信息

Vaccines (Basel). 2021 May 21;9(6):536. doi: 10.3390/vaccines9060536.

DOI:10.3390/vaccines9060536
PMID:34063785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8223771/
Abstract

Infections with the pathogen, , are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination should be offered. Here, we discuss the role of pneumococcal vaccination in specific groups of immunocompromised hosts.

摘要

感染病原体[此处原文缺失病原体名称]是全球发病和死亡的常见原因。它尤其影响年龄极端者和免疫功能低下的个体。在高危个体中预防肺炎球菌疾病至关重要，应提供肺炎球菌疫苗接种。在此，我们讨论肺炎球菌疫苗接种在特定免疫功能低下宿主群体中的作用。